BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 10952685)

  • 1. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
    Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
    Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
    Walch L; Clavarino E; Morris PL
    Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).
    Woodward DF; Krauss AH; Chen J; Liang Y; Li C; Protzman CE; Bogardus A; Chen R; Kedzie KM; Krauss HA; Gil DW; Kharlamb A; Wheeler LA; Babusis D; Welty D; Tang-Liu DD; Cherukury M; Andrews SW; Burk RM; Garst ME
    J Pharmacol Exp Ther; 2003 May; 305(2):772-85. PubMed ID: 12606640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
    Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
    J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
    Sametz W; Hennerbichler S; Glaser S; Wintersteiger R; Juan H
    Br J Pharmacol; 2000 Aug; 130(8):1903-10. PubMed ID: 10952681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
    Bhattacherjee P; Williams BS; Paterson CA
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
    Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
    J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-ring 8-isoprostanes are agonists at EP2- and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colony-stimulating factors by activating cAMP-dependent protein kinase.
    Clarke DL; Belvisi MG; Hardaker E; Newton R; Giembycz MA
    Mol Pharmacol; 2005 Feb; 67(2):383-93. PubMed ID: 15528403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 and F2alpha receptors in the human Fallopian tube before and after mifepristone treatment.
    Wånggren K; Lalitkumar PG; Stavreus-Evers A; Ståbi B; Gemzell-Danielsson K
    Mol Hum Reprod; 2006 Sep; 12(9):577-85. PubMed ID: 16820403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins E(2) and F(2alpha) enhance differentiation of cementoblastic cells.
    Camargo PM; Lagos R; Pirih FQ; Benitez A; Nervina JM; Tetradis S
    J Periodontol; 2005 Feb; 76(2):303-9. PubMed ID: 15974857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
    Kelly CR; Williams GW; Sharif NA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
    Sharif NA; Davis TL
    J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter.
    Ansari HR; Davis AM; Kaddour-Djebbar I; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):217-31. PubMed ID: 12828840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
    Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
    Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
    Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.
    Jones RL; Woodward DF
    Br J Pharmacol; 2011 Jan; 162(2):521-31. PubMed ID: 20955363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.